BOYLE J DAVID II 4
4 · AVI BIOPHARMA INC · Filed Mar 10, 2010
Insider Transaction Report
Form 4
Transactions
- Award
Incentive Stock Option (right to buy)
2010-03-09+10,000→ 10,000 totalExercise: $1.30From: 2011-03-09Exp: 2020-03-09→ Common Stock (10,000 underlying) - Award
Non-Qualified Stock Option (right to buy)
2010-03-09+90,000→ 90,000 totalExercise: $1.30From: 2011-03-09Exp: 2020-03-09→ Common Stock (90,000 underlying)
Holdings
- 100,000
Non-Qualified Stock Option (right to buy)
Exercise: $0.92From: 2010-02-10Exp: 2019-02-10→ Common Stock (100,000 underlying) - 65,282
Common Stock
- 97,241
Incentive Stock Option (right to buy)
Exercise: $1.45From: 2011-02-09Exp: 2020-02-09→ Common Stock (97,241 underlying) - 247,932
Incentive Stock Option (right to buy)
Exercise: $1.21From: 2008-08-18Exp: 2018-08-18→ Common Stock (247,932 underlying) - 50,000
Incentive Stock Option (right to buy)
Exercise: $0.92From: 2010-02-10Exp: 2019-02-10→ Common Stock (50,000 underlying) - 102,068
Non-Qualified Stock Option (right to buy)
Exercise: $1.21From: 2008-08-18Exp: 2018-08-18→ Common Stock (102,068 underlying) - 82,759
Non-Qualified Stock Option (right to buy)
Exercise: $1.45From: 2011-02-09Exp: 2020-02-09→ Common Stock (82,759 underlying)
Footnotes (3)
- [F1]The Stock Option Grant vest as follows: 1/3 vest one year from date of grant and 1/3 each year thereafter until all shares vest three years from grant date.
- [F2]Price not required on initial report of stock option granted.
- [F3]The options vest in equal annual installments over three years beginning on August 18, 2008.